Abstract
A competition radioimmunoassay was developed, utilizing a murine monoclonal antibody to human pancreatic adenocarcinoma cells. Immunoblotting of a standard antigen preparation from either serum or ascites fluid after electrophoresis in 1% agarose showed that the specific DU-PAN-2 activity resided in two major high molecular weight bands. DU-PAN-2 antigen levels were expressed as arbitrary units based on a standard partially purified antigen preparation. The inhibition curve with standard antigen was reproducible (SD less than 10%) and essentially linear from 25 to 200 units/ml. The mean DU-PAN-2 antigen concentration for the sera from 126 normal individuals was 81 units/ml. Sera from pediatric patients with malignancy had a mean of 127 units/ml, while nasopharyngeal, stage III melanoma, and ovarian carcinoma patients had means of 89, 92, and 119 units/ml, respectively. All values in normal subjects as well as the melanoma, nasopharyngeal, ovarian, and pediatric cancer patients were less than 400 units/ml. Intermediate antigen levels were detected in patients with alimentary tract malignancies. Eight of 20 gastric cancer and 8 of 76 colorectal carcinoma patients and 3 patients with benign or nonmalignant gastrointestinal tract disease had DU-PAN-2 values exceeding 400 units/ml. Ascites fluids from 6/6 and pancreatic juice from 2/2 pancreatic cancer patients had values greater than 750 units/ml. Serum from 68% of the 89 pancreatic cancer patients tested had DU-PAN-2 antigen levels greater than 400 units/ml. The mean serum value in this patient population was 4888 units/ml.
Full text
PDF![5242](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a530/391674/a5d6aaf37a6a/pnas00617-0242.png)
![5243](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a530/391674/b10e488e02ff/pnas00617-0243.png)
![5244](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a530/391674/7049d552dd95/pnas00617-0244.png)
![5245](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a530/391674/7b534c418d70/pnas00617-0245.png)
![5246](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a530/391674/2660833a4b78/pnas00617-0246.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Borowitz M. J., Tuck F. L., Sindelar W. F., Fernsten P. D., Metzgar R. S. Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas. J Natl Cancer Inst. 1984 May;72(5):999–1005. [PubMed] [Google Scholar]
- Creeth J. M., Bhaskar K. R., Horton J. R., Das I., Lopez-Vidriero M. T., Reid L. The separation and characterization of bronchial glycoproteins by density-gradient methods. Biochem J. 1977 Dec 1;167(3):557–569. doi: 10.1042/bj1670557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holden K. G., Yim N. C., Griggs L. J., Weisbach J. A. Gel electrophoresis of mucous glycoproteins. II. Effect of physical deaggregation and disulfide-bond cleavage. Biochemistry. 1971 Aug 3;10(16):3110–3113. doi: 10.1021/bi00792a020. [DOI] [PubMed] [Google Scholar]
- Koprowski H., Herlyn M., Steplewski Z., Sears H. F. Specific antigen in serum of patients with colon carcinoma. Science. 1981 Apr 3;212(4490):53–55. doi: 10.1126/science.6163212. [DOI] [PubMed] [Google Scholar]
- Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
- Magnani J. L., Steplewski Z., Koprowski H., Ginsburg V. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res. 1983 Nov;43(11):5489–5492. [PubMed] [Google Scholar]
- Metzgar R. S., Gaillard M. T., Levine S. J., Tuck F. L., Bossen E. H., Borowitz M. J. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Cancer Res. 1982 Feb;42(2):601–608. [PubMed] [Google Scholar]